| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹15,348 | +2.32% | |
| 6 months | ₹30,000 | ₹31,304 | +4.35% | |
| 1 year | ₹60,000 | ₹66,053 | +10.09% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 8.58% |
| Divi's Laboratories Ltd | Healthcare | Equity | 8.41% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 7.74% |
| Laurus Labs Ltd | Healthcare | Equity | 7.56% |
| Ipca Laboratories Ltd | Healthcare | Equity | 6.06% |
| Lupin Ltd | Healthcare | Equity | 5.86% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 5.58% |
| Fortis Healthcare Ltd | Healthcare | Equity | 4.06% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 3.13% |
| Others CBLO | Unspecified | CBLO | 2.95% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 2.89% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 2.80% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 2.45% |
| Astrazeneca Pharma India Ltd | Healthcare | Equity | 2.40% |
| Ami Organics Ltd | Healthcare | Equity | 2.27% |
| Abbott India Ltd | Healthcare | Equity | 2.15% |
| Mankind Pharma Ltd. | Healthcare | Equity | 2.09% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 2.00% |
| Max Financial Services Ltd | Financial | Equity | 1.97% |
| Concord Biotech Ltd. | Healthcare | Equity | 1.83% |
| Symbiotec Pharmalab Ltd. | Healthcare | Equity | 1.59% |
| Emcure Pharmaceuticals Ltd. | Healthcare | Equity | 1.57% |
| Ajanta Pharma Ltd | Healthcare | Equity | 1.54% |
| Paras Healthcare Ltd. | Healthcare | Equity | 1.53% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 1.42% |
| Nephrocare Health Services Ltd. | Healthcare | Equity | 1.35% |
| Gland Pharma Ltd | Healthcare | Equity | 1.30% |
| Metropolis Healthcare Ltd | Healthcare | Equity | 1.26% |
| Manipal Health Enterprises Ltd | Healthcare | Equity | 1.19% |
| Cipla Ltd | Healthcare | Equity | 1.16% |
| Narayana Hrudayalaya Ltd | Healthcare | Equity | 0.96% |
| Inventurus Knowledge Solutions Ltd. | Industrials | Equity | 0.89% |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | Equity | 0.78% |
| Life Insurance Corporation of India | Financial | Equity | 0.66% |
| Net Receivables | Unspecified | Net Receivables | 0.02% |
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | +2.6% | +9.0% | +14.2% | +9.8% |
| Category average (Equity Sectoral) | +3.4% | +10.9% | +19.0% | +493.8% |
| Rank (Equity Sectoral) | 25 | 26 | 24 | -- |